| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | extracellular matrix structural constituent | 1.27e-08 | 188 | 31 | 7 | GO:0005201 | |
| GeneOntologyMolecularFunction | calcium ion binding | 1.13e-07 | 749 | 31 | 10 | GO:0005509 | |
| GeneOntologyMolecularFunction | Notch binding | 9.66e-06 | 27 | 31 | 3 | GO:0005112 | |
| GeneOntologyMolecularFunction | scavenger receptor activity | 9.66e-06 | 27 | 31 | 3 | GO:0005044 | |
| GeneOntologyMolecularFunction | cargo receptor activity | 3.07e-04 | 85 | 31 | 3 | GO:0038024 | |
| GeneOntologyMolecularFunction | structural molecule activity | 3.53e-04 | 891 | 31 | 7 | GO:0005198 | |
| GeneOntologyMolecularFunction | cell adhesion molecule binding | 2.13e-03 | 599 | 31 | 5 | GO:0050839 | |
| GeneOntologyMolecularFunction | integrin binding | 2.48e-03 | 175 | 31 | 3 | GO:0005178 | |
| GeneOntologyBiologicalProcess | axon guidance | 1.77e-07 | 285 | 31 | 7 | GO:0007411 | |
| GeneOntologyBiologicalProcess | neuron projection guidance | 1.81e-07 | 286 | 31 | 7 | GO:0097485 | |
| GeneOntologyBiologicalProcess | animal organ morphogenesis | JAG2 LAMA3 LAMA5 LAMB2 LRP5 HSPG2 FAT1 SCUBE2 TENM3 MEGF11 NTN3 | 1.23e-06 | 1269 | 31 | 11 | GO:0009887 |
| GeneOntologyBiologicalProcess | cell morphogenesis involved in neuron differentiation | 1.08e-05 | 748 | 31 | 8 | GO:0048667 | |
| GeneOntologyBiologicalProcess | axonogenesis | 1.67e-05 | 566 | 31 | 7 | GO:0007409 | |
| GeneOntologyBiologicalProcess | extracellular matrix organization | 1.79e-05 | 377 | 31 | 6 | GO:0030198 | |
| GeneOntologyBiologicalProcess | neuron projection morphogenesis | 1.80e-05 | 802 | 31 | 8 | GO:0048812 | |
| GeneOntologyBiologicalProcess | extracellular structure organization | 1.82e-05 | 378 | 31 | 6 | GO:0043062 | |
| GeneOntologyBiologicalProcess | external encapsulating structure organization | 1.85e-05 | 379 | 31 | 6 | GO:0045229 | |
| GeneOntologyBiologicalProcess | cell-cell adhesion | 1.98e-05 | 1077 | 31 | 9 | GO:0098609 | |
| GeneOntologyBiologicalProcess | plasma membrane bounded cell projection morphogenesis | 2.09e-05 | 819 | 31 | 8 | GO:0120039 | |
| GeneOntologyBiologicalProcess | cell projection morphogenesis | 2.22e-05 | 826 | 31 | 8 | GO:0048858 | |
| GeneOntologyBiologicalProcess | homotypic cell-cell adhesion | 3.45e-05 | 124 | 31 | 4 | GO:0034109 | |
| GeneOntologyBiologicalProcess | axon development | 3.75e-05 | 642 | 31 | 7 | GO:0061564 | |
| GeneOntologyBiologicalProcess | cell morphogenesis | 4.48e-05 | 1194 | 31 | 9 | GO:0000902 | |
| GeneOntologyBiologicalProcess | recognition of apoptotic cell | 4.57e-05 | 7 | 31 | 2 | GO:0043654 | |
| GeneOntologyBiologicalProcess | apoptotic process involved in development | 4.77e-05 | 47 | 31 | 3 | GO:1902742 | |
| GeneOntologyBiologicalProcess | regulation of cell adhesion | 5.06e-05 | 927 | 31 | 8 | GO:0030155 | |
| GeneOntologyBiologicalProcess | neuron projection development | 7.93e-05 | 1285 | 31 | 9 | GO:0031175 | |
| GeneOntologyBiologicalProcess | camera-type eye morphogenesis | 1.20e-04 | 171 | 31 | 4 | GO:0048593 | |
| GeneOntologyBiologicalProcess | homophilic cell adhesion via plasma membrane adhesion molecules | 1.70e-04 | 187 | 31 | 4 | GO:0007156 | |
| GeneOntologyBiologicalProcess | positive regulation of integrin-mediated signaling pathway | 1.97e-04 | 14 | 31 | 2 | GO:2001046 | |
| GeneOntologyBiologicalProcess | neuron development | 2.14e-04 | 1463 | 31 | 9 | GO:0048666 | |
| GeneOntologyBiologicalProcess | eye morphogenesis | 2.37e-04 | 204 | 31 | 4 | GO:0048592 | |
| GeneOntologyBiologicalProcess | skeletal system development | 2.67e-04 | 615 | 31 | 6 | GO:0001501 | |
| GeneOntologyBiologicalProcess | camera-type eye development | 4.00e-04 | 426 | 31 | 5 | GO:0043010 | |
| GeneOntologyBiologicalProcess | regulation of integrin-mediated signaling pathway | 5.42e-04 | 23 | 31 | 2 | GO:2001044 | |
| GeneOntologyBiologicalProcess | epidermis development | 5.74e-04 | 461 | 31 | 5 | GO:0008544 | |
| GeneOntologyBiologicalProcess | sensory organ development | 6.65e-04 | 730 | 31 | 6 | GO:0007423 | |
| GeneOntologyBiologicalProcess | eye development | 6.89e-04 | 480 | 31 | 5 | GO:0001654 | |
| GeneOntologyBiologicalProcess | visual system development | 7.08e-04 | 483 | 31 | 5 | GO:0150063 | |
| GeneOntologyBiologicalProcess | skeletal system morphogenesis | 7.53e-04 | 277 | 31 | 4 | GO:0048705 | |
| GeneOntologyBiologicalProcess | sensory system development | 7.63e-04 | 491 | 31 | 5 | GO:0048880 | |
| GeneOntologyBiologicalProcess | bone morphogenesis | 8.43e-04 | 124 | 31 | 3 | GO:0060349 | |
| GeneOntologyBiologicalProcess | integrin-mediated signaling pathway | 8.43e-04 | 124 | 31 | 3 | GO:0007229 | |
| GeneOntologyBiologicalProcess | apoptotic process involved in morphogenesis | 1.05e-03 | 32 | 31 | 2 | GO:0060561 | |
| GeneOntologyBiologicalProcess | cell-cell adhesion via plasma-membrane adhesion molecules | 1.18e-03 | 313 | 31 | 4 | GO:0098742 | |
| GeneOntologyBiologicalProcess | positive regulation of vascular associated smooth muscle cell migration | 1.33e-03 | 36 | 31 | 2 | GO:1904754 | |
| GeneOntologyBiologicalProcess | plasma lipoprotein particle remodeling | 1.33e-03 | 36 | 31 | 2 | GO:0034369 | |
| GeneOntologyBiologicalProcess | protein-lipid complex remodeling | 1.33e-03 | 36 | 31 | 2 | GO:0034368 | |
| GeneOntologyBiologicalProcess | protein-containing complex remodeling | 1.56e-03 | 39 | 31 | 2 | GO:0034367 | |
| GeneOntologyBiologicalProcess | sensory organ morphogenesis | 1.66e-03 | 343 | 31 | 4 | GO:0090596 | |
| GeneOntologyBiologicalProcess | muscle cell migration | 1.79e-03 | 161 | 31 | 3 | GO:0014812 | |
| GeneOntologyBiologicalProcess | phagocytosis, recognition | 1.81e-03 | 42 | 31 | 2 | GO:0006910 | |
| GeneOntologyBiologicalProcess | basement membrane organization | 1.90e-03 | 43 | 31 | 2 | GO:0071711 | |
| GeneOntologyBiologicalProcess | skin epidermis development | 1.95e-03 | 166 | 31 | 3 | GO:0098773 | |
| GeneOntologyBiologicalProcess | morphogenesis of an epithelium | 2.13e-03 | 619 | 31 | 5 | GO:0002009 | |
| GeneOntologyBiologicalProcess | cartilage development involved in endochondral bone morphogenesis | 2.27e-03 | 47 | 31 | 2 | GO:0060351 | |
| GeneOntologyBiologicalProcess | apoptotic cell clearance | 2.36e-03 | 48 | 31 | 2 | GO:0043277 | |
| GeneOntologyCellularComponent | basement membrane | 4.54e-10 | 122 | 31 | 7 | GO:0005604 | |
| GeneOntologyCellularComponent | collagen-containing extracellular matrix | 4.96e-08 | 530 | 31 | 9 | GO:0062023 | |
| GeneOntologyCellularComponent | extracellular matrix | 3.03e-07 | 656 | 31 | 9 | GO:0031012 | |
| GeneOntologyCellularComponent | external encapsulating structure | 3.11e-07 | 658 | 31 | 9 | GO:0030312 | |
| GeneOntologyCellularComponent | laminin complex | 3.52e-07 | 10 | 31 | 3 | GO:0043256 | |
| GeneOntologyCellularComponent | laminin-11 complex | 6.38e-06 | 3 | 31 | 2 | GO:0043260 | |
| GeneOntologyCellularComponent | laminin-3 complex | 6.38e-06 | 3 | 31 | 2 | GO:0005608 | |
| GeneOntologyCellularComponent | laminin-5 complex | 1.27e-05 | 4 | 31 | 2 | GO:0005610 | |
| GeneOntologyCellularComponent | phagocytic cup | 9.64e-04 | 31 | 31 | 2 | GO:0001891 | |
| GeneOntologyCellularComponent | synaptic cleft | 1.09e-03 | 33 | 31 | 2 | GO:0043083 | |
| GeneOntologyCellularComponent | cell-substrate junction | 3.98e-03 | 443 | 31 | 4 | GO:0030055 | |
| GeneOntologyCellularComponent | cornified envelope | 4.69e-03 | 69 | 31 | 2 | GO:0001533 | |
| HumanPheno | Elevated circulating hepcidin concentration | 2.42e-05 | 3 | 15 | 2 | HP:0031877 | |
| HumanPheno | Abnormal circulating hepcidin concentration | 4.84e-05 | 4 | 15 | 2 | HP:0031875 | |
| MousePheno | abnormal sensory neuron morphology | 2.39e-05 | 473 | 27 | 7 | MP:0000965 | |
| MousePheno | abnormal somatic nervous system morphology | 8.28e-05 | 1025 | 27 | 9 | MP:0002752 | |
| MousePheno | fused podocyte foot processes | 1.60e-04 | 10 | 27 | 2 | MP:0008139 | |
| MousePheno | absent neurocranium | 1.95e-04 | 11 | 27 | 2 | MP:0000075 | |
| MousePheno | impaired basement membrane formation | 1.95e-04 | 11 | 27 | 2 | MP:0003044 | |
| Domain | EGF | JAG2 DLK2 PCSK5 LAMA3 LAMA5 LAMB2 LRP5 HSPG2 FAT1 SCUBE2 HMCN1 TENM3 MEGF11 MEGF10 MATN2 PEAR1 STAB1 | 6.28e-25 | 235 | 31 | 17 | SM00181 |
| Domain | EGF-like_dom | JAG2 DLK2 PCSK5 LAMA3 LAMA5 LAMB2 LRP5 HSPG2 FAT1 SCUBE2 HMCN1 TENM3 MEGF11 MEGF10 MATN2 PEAR1 STAB1 | 1.72e-24 | 249 | 31 | 17 | IPR000742 |
| Domain | EGF-like_CS | JAG2 DLK2 LAMA3 LAMA5 LAMB2 LRP5 HSPG2 FAT1 SCUBE2 HMCN1 TENM3 MEGF11 MEGF10 MATN2 NTN3 PEAR1 STAB1 | 3.90e-24 | 261 | 31 | 17 | IPR013032 |
| Domain | EGF_2 | JAG2 DLK2 LAMA3 LAMA5 LAMB2 LRP5 HSPG2 FAT1 SCUBE2 HMCN1 TENM3 MEGF11 MEGF10 MATN2 NTN3 PEAR1 STAB1 | 5.07e-24 | 265 | 31 | 17 | PS01186 |
| Domain | EGF_1 | JAG2 DLK2 LAMA3 LAMA5 LAMB2 LRP5 HSPG2 FAT1 SCUBE2 HMCN1 TENM3 MEGF11 MEGF10 NTN3 PEAR1 STAB1 | 2.27e-22 | 255 | 31 | 16 | PS00022 |
| Domain | Laminin_EGF | 1.82e-18 | 35 | 31 | 9 | PF00053 | |
| Domain | EGF_Lam | 1.82e-18 | 35 | 31 | 9 | SM00180 | |
| Domain | Laminin_EGF | 4.19e-18 | 38 | 31 | 9 | IPR002049 | |
| Domain | Growth_fac_rcpt_ | JAG2 PCSK5 LAMA3 LAMA5 LAMB2 HSPG2 FAT1 SCUBE2 HMCN1 MATN2 NTN3 STAB1 | 9.24e-18 | 156 | 31 | 12 | IPR009030 |
| Domain | EGF_3 | JAG2 DLK2 LRP5 HSPG2 FAT1 SCUBE2 HMCN1 TENM3 MEGF11 MEGF10 MATN2 PEAR1 STAB1 | 2.40e-17 | 235 | 31 | 13 | PS50026 |
| Domain | EGF-like_Ca-bd_dom | 3.33e-13 | 124 | 31 | 9 | IPR001881 | |
| Domain | EGF | 3.85e-13 | 126 | 31 | 9 | PF00008 | |
| Domain | EGF_LAM_2 | 7.22e-12 | 30 | 31 | 6 | PS50027 | |
| Domain | EGF_LAM_1 | 7.22e-12 | 30 | 31 | 6 | PS01248 | |
| Domain | EGF_CA | 1.83e-11 | 122 | 31 | 8 | SM00179 | |
| Domain | EGF_extracell | 5.88e-10 | 60 | 31 | 6 | IPR013111 | |
| Domain | EGF_2 | 5.88e-10 | 60 | 31 | 6 | PF07974 | |
| Domain | LAMININ_NTER | 1.11e-08 | 16 | 31 | 4 | PS51117 | |
| Domain | Laminin_N | 1.11e-08 | 16 | 31 | 4 | PF00055 | |
| Domain | Laminin_N | 1.11e-08 | 16 | 31 | 4 | IPR008211 | |
| Domain | LamNT | 1.11e-08 | 16 | 31 | 4 | SM00136 | |
| Domain | EGF_CA | 1.26e-08 | 99 | 31 | 6 | PS01187 | |
| Domain | ASX_HYDROXYL | 1.34e-08 | 100 | 31 | 6 | PS00010 | |
| Domain | EGF-type_Asp/Asn_hydroxyl_site | 1.90e-08 | 106 | 31 | 6 | IPR000152 | |
| Domain | hEGF | 1.24e-07 | 28 | 31 | 4 | PF12661 | |
| Domain | LAMININ_IVA | 2.31e-07 | 8 | 31 | 3 | PS51115 | |
| Domain | Laminin_B | 2.31e-07 | 8 | 31 | 3 | PF00052 | |
| Domain | LamB | 2.31e-07 | 8 | 31 | 3 | SM00281 | |
| Domain | Laminin_IV | 2.31e-07 | 8 | 31 | 3 | IPR000034 | |
| Domain | EGF_CA | 2.85e-07 | 86 | 31 | 5 | PF07645 | |
| Domain | LAM_G_DOMAIN | 4.41e-07 | 38 | 31 | 4 | PS50025 | |
| Domain | EGF_Ca-bd_CS | 5.20e-07 | 97 | 31 | 5 | IPR018097 | |
| Domain | Laminin_G_2 | 5.44e-07 | 40 | 31 | 4 | PF02210 | |
| Domain | LamG | 8.05e-07 | 44 | 31 | 4 | SM00282 | |
| Domain | EMI_domain | 2.28e-06 | 16 | 31 | 3 | IPR011489 | |
| Domain | Laminin_G | 2.47e-06 | 58 | 31 | 4 | IPR001791 | |
| Domain | EMI | 2.77e-06 | 17 | 31 | 3 | PS51041 | |
| Domain | VWC_out | 3.94e-06 | 19 | 31 | 3 | SM00215 | |
| Domain | cEGF | 1.05e-05 | 26 | 31 | 3 | IPR026823 | |
| Domain | cEGF | 1.05e-05 | 26 | 31 | 3 | PF12662 | |
| Domain | Galactose-bd-like | 1.71e-05 | 94 | 31 | 4 | IPR008979 | |
| Domain | - | 1.78e-05 | 95 | 31 | 4 | 2.60.120.200 | |
| Domain | Laminin_aI | 2.66e-05 | 5 | 31 | 2 | IPR009254 | |
| Domain | Laminin_I | 2.66e-05 | 5 | 31 | 2 | PF06008 | |
| Domain | Laminin_II | 2.66e-05 | 5 | 31 | 2 | PF06009 | |
| Domain | Laminin_domII | 2.66e-05 | 5 | 31 | 2 | IPR010307 | |
| Domain | VWFC_1 | 2.85e-05 | 36 | 31 | 3 | PS01208 | |
| Domain | VWC | 3.36e-05 | 38 | 31 | 3 | SM00214 | |
| Domain | VWFC_2 | 3.36e-05 | 38 | 31 | 3 | PS50184 | |
| Domain | VWF_dom | 4.55e-05 | 42 | 31 | 3 | IPR001007 | |
| Domain | Ldl_recept_a | 5.60e-05 | 45 | 31 | 3 | PF00057 | |
| Domain | - | 5.99e-05 | 46 | 31 | 3 | 4.10.400.10 | |
| Domain | LDLRA_1 | 6.81e-05 | 48 | 31 | 3 | PS01209 | |
| Domain | LDrepeatLR_classA_rpt | 7.24e-05 | 49 | 31 | 3 | IPR002172 | |
| Domain | LDLa | 7.24e-05 | 49 | 31 | 3 | SM00192 | |
| Domain | LDLRA_2 | 7.24e-05 | 49 | 31 | 3 | PS50068 | |
| Domain | - | 1.45e-04 | 11 | 31 | 2 | 2.40.155.10 | |
| Domain | GFP-like | 1.45e-04 | 11 | 31 | 2 | IPR023413 | |
| Domain | EGF_3 | 1.74e-04 | 12 | 31 | 2 | PF12947 | |
| Domain | EGF_dom | 1.74e-04 | 12 | 31 | 2 | IPR024731 | |
| Domain | Unchr_dom_Cys-rich | 2.06e-04 | 13 | 31 | 2 | IPR014853 | |
| Domain | C8 | 2.06e-04 | 13 | 31 | 2 | SM00832 | |
| Domain | TIL_dom | 2.40e-04 | 14 | 31 | 2 | IPR002919 | |
| Domain | - | 2.48e-04 | 74 | 31 | 3 | 3.40.50.410 | |
| Domain | VWFD | 3.15e-04 | 16 | 31 | 2 | PS51233 | |
| Domain | VWD | 3.15e-04 | 16 | 31 | 2 | SM00216 | |
| Domain | VWF_type-D | 3.15e-04 | 16 | 31 | 2 | IPR001846 | |
| Domain | VWD | 3.15e-04 | 16 | 31 | 2 | PF00094 | |
| Domain | VWFA | 3.36e-04 | 82 | 31 | 3 | PS50234 | |
| Domain | VWA | 3.60e-04 | 84 | 31 | 3 | SM00327 | |
| Domain | ConA-like_dom | 4.51e-04 | 219 | 31 | 4 | IPR013320 | |
| Domain | VWF_A | 5.83e-04 | 99 | 31 | 3 | IPR002035 | |
| Domain | SEA | 6.03e-04 | 22 | 31 | 2 | PF01390 | |
| Domain | SEA | 6.60e-04 | 23 | 31 | 2 | PS50024 | |
| Domain | SEA_dom | 6.60e-04 | 23 | 31 | 2 | IPR000082 | |
| Domain | Ephrin_rec_like | 7.81e-04 | 25 | 31 | 2 | SM01411 | |
| Domain | Tyr-kin_ephrin_A/B_rcpt-like | 7.81e-04 | 25 | 31 | 2 | IPR011641 | |
| Domain | VWC | 9.81e-04 | 28 | 31 | 2 | PF00093 | |
| Domain | - | 1.90e-03 | 39 | 31 | 2 | 2.120.10.30 | |
| Domain | LDLR_class-A_CS | 2.00e-03 | 40 | 31 | 2 | IPR023415 | |
| Domain | 6-blade_b-propeller_TolB-like | 2.64e-03 | 46 | 31 | 2 | IPR011042 | |
| Domain | CUB | 3.11e-03 | 50 | 31 | 2 | SM00042 | |
| Domain | - | 3.36e-03 | 52 | 31 | 2 | 2.60.120.290 | |
| Domain | CUB | 3.49e-03 | 53 | 31 | 2 | PS01180 | |
| Pathway | REACTOME_LAMININ_INTERACTIONS | 1.19e-07 | 30 | 22 | 4 | M27216 | |
| Pathway | KEGG_ECM_RECEPTOR_INTERACTION | 1.62e-07 | 84 | 22 | 5 | M7098 | |
| Pathway | PID_INTEGRIN4_PATHWAY | 5.40e-07 | 11 | 22 | 3 | M158 | |
| Pathway | REACTOME_NON_INTEGRIN_MEMBRANE_ECM_INTERACTIONS | 1.91e-06 | 59 | 22 | 4 | M27218 | |
| Pathway | WP_PRIMARY_FOCAL_SEGMENTAL_GLOMERULOSCLEROSIS_FSGS | 4.27e-06 | 72 | 22 | 4 | M39403 | |
| Pathway | WP_PRIMARY_FOCAL_SEGMENTAL_GLOMERULOSCLEROSIS_FSGS | 4.51e-06 | 73 | 22 | 4 | MM15906 | |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | 4.95e-06 | 300 | 22 | 6 | M610 | |
| Pathway | REACTOME_ECM_PROTEOGLYCANS | 5.30e-06 | 76 | 22 | 4 | M27219 | |
| Pathway | KEGG_SMALL_CELL_LUNG_CANCER | 7.91e-06 | 84 | 22 | 4 | M3228 | |
| Pathway | REACTOME_MET_ACTIVATES_PTK2_SIGNALING | 1.30e-05 | 30 | 22 | 3 | M27772 | |
| Pathway | WP_SMALL_CELL_LUNG_CANCER | 1.34e-05 | 96 | 22 | 4 | M39834 | |
| Pathway | WP_ALPHA_6_BETA_4_SIGNALING | 1.75e-05 | 33 | 22 | 3 | M39503 | |
| Pathway | REACTOME_MET_PROMOTES_CELL_MOTILITY | 3.38e-05 | 41 | 22 | 3 | M27778 | |
| Pathway | PID_A6B1_A6B4_INTEGRIN_PATHWAY | 4.79e-05 | 46 | 22 | 3 | M239 | |
| Pathway | REACTOME_DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX | 5.93e-05 | 140 | 22 | 4 | M587 | |
| Pathway | WP_CANCER_PATHWAYS | 9.59e-05 | 507 | 22 | 6 | M48302 | |
| Pathway | WP_ALPHA_6_BETA_4_INTEGRIN_SIGNALING_PATHWAY | 1.42e-04 | 66 | 22 | 3 | MM15925 | |
| Pathway | PID_INTEGRIN1_PATHWAY | 1.42e-04 | 66 | 22 | 3 | M18 | |
| Pathway | WP_FOCAL_ADHESION | 1.82e-04 | 187 | 22 | 4 | MM15913 | |
| Pathway | WP_FOCAL_ADHESION | 2.31e-04 | 199 | 22 | 4 | M39402 | |
| Pathway | KEGG_FOCAL_ADHESION | 2.31e-04 | 199 | 22 | 4 | M7253 | |
| Pathway | REACTOME_SIGNALING_BY_MET | 2.42e-04 | 79 | 22 | 3 | M27643 | |
| Pathway | WP_PLEURAL_MESOTHELIOMA | 4.86e-04 | 439 | 22 | 5 | M42563 | |
| Pathway | WP_CANONICAL_AND_NONCANONICAL_NOTCH_SIGNALING | 7.97e-04 | 27 | 22 | 2 | M39545 | |
| Pathway | WP_INFLAMMATORY_RESPONSE_PATHWAY | 9.85e-04 | 30 | 22 | 2 | M39641 | |
| Pathway | WP_INFLAMMATORY_RESPONSE_PATHWAY | 9.85e-04 | 30 | 22 | 2 | MM15812 | |
| Pathway | WP_FOCAL_ADHESION_PI3KAKTMTORSIGNALING | 1.11e-03 | 302 | 22 | 4 | M39719 | |
| Pathway | WP_HAIR_FOLLICLE_DEVELOPMENT_ORGANOGENESIS_STAGE_2_OF_3 | 1.12e-03 | 32 | 22 | 2 | M40041 | |
| Pathway | KEGG_PATHWAYS_IN_CANCER | 1.46e-03 | 325 | 22 | 4 | M12868 | |
| Pathway | WP_FOCAL_ADHESION_PI3KAKTMTOR_SIGNALING_PATHWAY | 1.48e-03 | 326 | 22 | 4 | MM15917 | |
| Pathway | WP_PI3KAKT_SIGNALING | 1.71e-03 | 339 | 22 | 4 | M39736 | |
| Pubmed | 8.26e-16 | 118 | 31 | 9 | 21078624 | ||
| Pubmed | 1.24e-10 | 167 | 31 | 7 | 22159717 | ||
| Pubmed | 1.72e-10 | 175 | 31 | 7 | 28071719 | ||
| Pubmed | Basement membrane composition in the early mouse embryo day 7. | 7.00e-10 | 15 | 31 | 4 | 15895400 | |
| Pubmed | Protein interactome reveals converging molecular pathways among autism disorders. | 1.00e-09 | 560 | 31 | 9 | 21653829 | |
| Pubmed | 3.33e-09 | 146 | 31 | 6 | 27068509 | ||
| Pubmed | 1.21e-08 | 29 | 31 | 4 | 22613833 | ||
| Pubmed | Glial precursors clear sensory neuron corpses during development via Jedi-1, an engulfment receptor. | 2.24e-08 | 7 | 31 | 3 | 19915564 | |
| Pubmed | 7.66e-08 | 10 | 31 | 3 | 9034910 | ||
| Pubmed | Extracellular matrix secretion by cardiac fibroblasts: role of microRNA-29b and microRNA-30c. | 7.85e-08 | 248 | 31 | 6 | 24006456 | |
| Pubmed | Regional differences in the expression of laminin isoforms during mouse neural tube development. | 1.05e-07 | 11 | 31 | 3 | 21524702 | |
| Pubmed | Characterization of the Extracellular Matrix of Normal and Diseased Tissues Using Proteomics. | 1.28e-07 | 135 | 31 | 5 | 28675934 | |
| Pubmed | 1.40e-07 | 12 | 31 | 3 | 16750824 | ||
| Pubmed | 1.40e-07 | 12 | 31 | 3 | 9396756 | ||
| Pubmed | 1.82e-07 | 13 | 31 | 3 | 12682087 | ||
| Pubmed | 2.39e-07 | 153 | 31 | 5 | 25037231 | ||
| Pubmed | 2.90e-07 | 15 | 31 | 3 | 31812516 | ||
| Pubmed | 3.16e-07 | 64 | 31 | 4 | 22261194 | ||
| Pubmed | 3.56e-07 | 16 | 31 | 3 | 17601529 | ||
| Pubmed | 5.18e-07 | 18 | 31 | 3 | 11311202 | ||
| Pubmed | ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1. | 6.88e-07 | 1201 | 31 | 9 | 35696571 | |
| Pubmed | 7.23e-07 | 20 | 31 | 3 | 22911573 | ||
| Pubmed | Transcriptome-based systematic identification of extracellular matrix proteins. | 7.40e-07 | 79 | 31 | 4 | 18757743 | |
| Pubmed | The mammalian Ced-1 ortholog MEGF10/KIAA1780 displays a novel adhesion pattern. | 7.69e-07 | 2 | 31 | 2 | 17498693 | |
| Pubmed | 7.69e-07 | 2 | 31 | 2 | 12382139 | ||
| Pubmed | Biological function of laminin-5 and pathogenic impact of its deficiency. | 7.69e-07 | 2 | 31 | 2 | 17000025 | |
| Pubmed | 8.19e-07 | 81 | 31 | 4 | 39217171 | ||
| Pubmed | 8.44e-07 | 21 | 31 | 3 | 27856617 | ||
| Pubmed | 8.81e-07 | 608 | 31 | 7 | 16713569 | ||
| Pubmed | 1.64e-06 | 26 | 31 | 3 | 24742657 | ||
| Pubmed | Proteomics characterization of extracellular space components in the human aorta. | 1.98e-06 | 101 | 31 | 4 | 20551380 | |
| Pubmed | 2.31e-06 | 3 | 31 | 2 | 10481268 | ||
| Pubmed | 2.31e-06 | 3 | 31 | 2 | 16886065 | ||
| Pubmed | Globular domains 4/5 of the laminin alpha3 chain mediate deposition of precursor laminin 5. | 2.31e-06 | 3 | 31 | 2 | 15316072 | |
| Pubmed | 2.31e-06 | 3 | 31 | 2 | 9049978 | ||
| Pubmed | The role of laminins in the organization and function of neuromuscular junctions. | 2.31e-06 | 3 | 31 | 2 | 27614294 | |
| Pubmed | 2.83e-06 | 31 | 31 | 3 | 22274697 | ||
| Pubmed | 4.61e-06 | 4 | 31 | 2 | 10651091 | ||
| Pubmed | 4.61e-06 | 4 | 31 | 2 | 29091766 | ||
| Pubmed | Jedi-1 and MEGF10 signal engulfment of apoptotic neurons through the tyrosine kinase Syk. | 4.61e-06 | 4 | 31 | 2 | 22993420 | |
| Pubmed | 4.61e-06 | 4 | 31 | 2 | 19752234 | ||
| Pubmed | Regulation and Function of Laminin A5 during Mouse and Human Decidualization. | 4.61e-06 | 4 | 31 | 2 | 35008625 | |
| Pubmed | 4.61e-06 | 4 | 31 | 2 | 34174923 | ||
| Pubmed | 4.61e-06 | 4 | 31 | 2 | 8081888 | ||
| Pubmed | 6.19e-06 | 40 | 31 | 3 | 27068110 | ||
| Pubmed | Laminins promote postsynaptic maturation by an autocrine mechanism at the neuromuscular junction. | 7.68e-06 | 5 | 31 | 2 | 18794334 | |
| Pubmed | 7.68e-06 | 5 | 31 | 2 | 11969289 | ||
| Pubmed | 7.68e-06 | 5 | 31 | 2 | 7670489 | ||
| Pubmed | Multiple functions of the integrin alpha6beta4 in epidermal homeostasis and tumorigenesis. | 7.68e-06 | 5 | 31 | 2 | 16581764 | |
| Pubmed | 7.68e-06 | 5 | 31 | 2 | 11829758 | ||
| Pubmed | 7.68e-06 | 5 | 31 | 2 | 10964500 | ||
| Pubmed | 7.68e-06 | 5 | 31 | 2 | 20684947 | ||
| Pubmed | Regulation of melanoma cell migration and invasion by laminin-5 and alpha3beta1 integrin (VLA-3). | 7.68e-06 | 5 | 31 | 2 | 11964076 | |
| Pubmed | 7.68e-06 | 5 | 31 | 2 | 12743034 | ||
| Pubmed | Differential expression of five laminin alpha (1-5) chains in developing and adult mouse kidney. | 7.68e-06 | 5 | 31 | 2 | 9415429 | |
| Pubmed | Differential expression of laminin alpha chains during murine tooth development. | 7.68e-06 | 5 | 31 | 2 | 9389447 | |
| Pubmed | A synaptic nidogen: developmental regulation and role of nidogen-2 at the neuromuscular junction. | 1.15e-05 | 6 | 31 | 2 | 18817539 | |
| Pubmed | 1.15e-05 | 6 | 31 | 2 | 15668394 | ||
| Pubmed | 1.15e-05 | 6 | 31 | 2 | 9597096 | ||
| Pubmed | Laminin-10 and Lutheran blood group glycoproteins in adhesion of human endothelial cells. | 1.15e-05 | 6 | 31 | 2 | 16236823 | |
| Pubmed | 1.15e-05 | 6 | 31 | 2 | 10671376 | ||
| Pubmed | 1.20e-05 | 591 | 31 | 6 | 15231748 | ||
| Pubmed | Sox9 plays multiple roles in the lung epithelium during branching morphogenesis. | 1.22e-05 | 50 | 31 | 3 | 24191021 | |
| Pubmed | 1.36e-05 | 164 | 31 | 4 | 32409323 | ||
| Pubmed | Laminins promote the locomotion of skeletal myoblasts via the alpha 7 integrin receptor. | 1.61e-05 | 7 | 31 | 2 | 9004048 | |
| Pubmed | 1.61e-05 | 7 | 31 | 2 | 7921537 | ||
| Pubmed | 1.61e-05 | 7 | 31 | 2 | 14557481 | ||
| Pubmed | 1.61e-05 | 7 | 31 | 2 | 11891225 | ||
| Pubmed | 2.15e-05 | 8 | 31 | 2 | 9852162 | ||
| Pubmed | 2.15e-05 | 8 | 31 | 2 | 8872465 | ||
| Pubmed | Spatial and temporal control of laminin-332 and -511 expressions during hair morphogenesis. | 2.15e-05 | 8 | 31 | 2 | 23529140 | |
| Pubmed | Expression and localization of laminin-5 subunits during mouse tooth development. | 2.15e-05 | 8 | 31 | 2 | 9489770 | |
| Pubmed | The extracellular-matrix protein matrilin 2 participates in peripheral nerve regeneration. | 2.76e-05 | 9 | 31 | 2 | 19295126 | |
| Pubmed | Laminin γ1 C-terminal Glu to Gln mutation induces early postimplantation lethality. | 2.76e-05 | 9 | 31 | 2 | 30456378 | |
| Pubmed | 3.44e-05 | 10 | 31 | 2 | 12724416 | ||
| Pubmed | Integrin alpha6beta1-laminin interactions regulate early myotome formation in the mouse embryo. | 3.44e-05 | 10 | 31 | 2 | 16554364 | |
| Pubmed | Generation of a conditionally null allele of the laminin alpha1 gene. | 3.44e-05 | 10 | 31 | 2 | 16100707 | |
| Pubmed | 3.85e-05 | 214 | 31 | 4 | 22199357 | ||
| Pubmed | 4.21e-05 | 11 | 31 | 2 | 12051813 | ||
| Pubmed | Anuria, omphalocele, and perinatal lethality in mice lacking the CD34-related protein podocalyxin. | 4.21e-05 | 11 | 31 | 2 | 11435469 | |
| Pubmed | Mutations in LAMB1 cause cobblestone brain malformation without muscular or ocular abnormalities. | 4.21e-05 | 11 | 31 | 2 | 23472759 | |
| Pubmed | Novel role for Netrins in regulating epithelial behavior during lung branching morphogenesis. | 4.21e-05 | 11 | 31 | 2 | 15186747 | |
| Pubmed | SVEP1 is an endogenous ligand for the orphan receptor PEAR1. | 4.21e-05 | 11 | 31 | 2 | 36792666 | |
| Pubmed | Beta4 integrin is required for hemidesmosome formation, cell adhesion and cell survival. | 4.21e-05 | 11 | 31 | 2 | 8707838 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | 4.32e-05 | 1105 | 31 | 7 | 35748872 | |
| Pubmed | 5.05e-05 | 12 | 31 | 2 | 10433923 | ||
| Pubmed | 5.96e-05 | 13 | 31 | 2 | 36350252 | ||
| Pubmed | 5.96e-05 | 13 | 31 | 2 | 9670011 | ||
| Pubmed | Fukutin-related protein alters the deposition of laminin in the eye and brain. | 5.96e-05 | 13 | 31 | 2 | 21900571 | |
| Pubmed | 6.95e-05 | 14 | 31 | 2 | 9151674 | ||
| Pubmed | Membrane-type MMPs are indispensable for placental labyrinth formation and development. | 6.95e-05 | 14 | 31 | 2 | 20858856 | |
| Pubmed | 6.95e-05 | 14 | 31 | 2 | 36347239 | ||
| Pubmed | 6.95e-05 | 14 | 31 | 2 | 19783738 | ||
| Pubmed | Laminin alpha5 chain is required for intestinal smooth muscle development. | 8.02e-05 | 15 | 31 | 2 | 12921739 | |
| Pubmed | 8.02e-05 | 15 | 31 | 2 | 9264260 | ||
| Pubmed | Glycoproteomics Reveals Decorin Peptides With Anti-Myostatin Activity in Human Atrial Fibrillation. | 8.93e-05 | 97 | 31 | 3 | 27559042 | |
| Pubmed | Ontogeny of stromal organizer cells during lymph node development. | 9.16e-05 | 16 | 31 | 2 | 20237296 | |
| Pubmed | 9.16e-05 | 16 | 31 | 2 | 30579834 | ||
| Pubmed | Patterns of laminins and integrins in the embryonic ventricular zone of the CNS. | 9.16e-05 | 16 | 31 | 2 | 17948866 | |
| Pubmed | Laminin-511 and integrin beta-1 in hair follicle development and basal cell carcinoma formation. | 9.16e-05 | 16 | 31 | 2 | 21067603 | |
| Interaction | CACNA1A interactions | 6.18e-10 | 123 | 31 | 7 | int:CACNA1A | |
| Interaction | IGFL3 interactions | 1.48e-09 | 75 | 31 | 6 | int:IGFL3 | |
| Interaction | IL5RA interactions | 3.12e-08 | 124 | 31 | 6 | int:IL5RA | |
| Interaction | HOXA1 interactions | 4.85e-08 | 356 | 31 | 8 | int:HOXA1 | |
| Interaction | PI15 interactions | 1.64e-07 | 83 | 31 | 5 | int:PI15 | |
| Interaction | SIRPD interactions | 1.96e-07 | 86 | 31 | 5 | int:SIRPD | |
| Interaction | EDN3 interactions | 6.12e-07 | 108 | 31 | 5 | int:EDN3 | |
| Interaction | ATXN7 interactions | 6.41e-07 | 109 | 31 | 5 | int:ATXN7 | |
| Interaction | CEACAM8 interactions | 9.91e-07 | 119 | 31 | 5 | int:CEACAM8 | |
| Interaction | GML interactions | 1.83e-06 | 58 | 31 | 4 | int:GML | |
| Interaction | FBXO2 interactions | 2.40e-06 | 411 | 31 | 7 | int:FBXO2 | |
| Interaction | NOXA1 interactions | 2.56e-06 | 63 | 31 | 4 | int:NOXA1 | |
| Interaction | NUFIP2 interactions | 2.64e-06 | 417 | 31 | 7 | int:NUFIP2 | |
| Interaction | PRG2 interactions | 4.15e-06 | 285 | 31 | 6 | int:PRG2 | |
| Interaction | C1orf54 interactions | 5.25e-06 | 167 | 31 | 5 | int:C1orf54 | |
| Interaction | CST9L interactions | 6.03e-06 | 78 | 31 | 4 | int:CST9L | |
| Interaction | GPHA2 interactions | 7.41e-06 | 25 | 31 | 3 | int:GPHA2 | |
| Interaction | SDF2L1 interactions | 8.35e-06 | 322 | 31 | 6 | int:SDF2L1 | |
| Interaction | NID2 interactions | 8.91e-06 | 86 | 31 | 4 | int:NID2 | |
| Interaction | OS9 interactions | 1.95e-05 | 219 | 31 | 5 | int:OS9 | |
| Interaction | BCAN interactions | 2.27e-05 | 36 | 31 | 3 | int:BCAN | |
| Interaction | PLA2G10 interactions | 2.62e-05 | 113 | 31 | 4 | int:PLA2G10 | |
| Interaction | NCR3 interactions | 3.32e-05 | 120 | 31 | 4 | int:NCR3 | |
| Interaction | LLCFC1 interactions | 3.43e-05 | 121 | 31 | 4 | int:LLCFC1 | |
| Interaction | LYPD4 interactions | 3.66e-05 | 123 | 31 | 4 | int:LYPD4 | |
| Interaction | SLAMF1 interactions | 3.90e-05 | 125 | 31 | 4 | int:SLAMF1 | |
| Interaction | CFC1 interactions | 4.02e-05 | 126 | 31 | 4 | int:CFC1 | |
| Interaction | DNASE2B interactions | 4.18e-05 | 44 | 31 | 3 | int:DNASE2B | |
| Interaction | GPIHBP1 interactions | 4.97e-05 | 133 | 31 | 4 | int:GPIHBP1 | |
| Interaction | SUSD4 interactions | 6.15e-05 | 50 | 31 | 3 | int:SUSD4 | |
| Interaction | SLURP1 interactions | 6.77e-05 | 144 | 31 | 4 | int:SLURP1 | |
| Interaction | MFAP5 interactions | 6.92e-05 | 52 | 31 | 3 | int:MFAP5 | |
| Interaction | ITGA6 interactions | 9.24e-05 | 156 | 31 | 4 | int:ITGA6 | |
| Interaction | LYPD1 interactions | 9.60e-05 | 58 | 31 | 3 | int:LYPD1 | |
| Interaction | INSL5 interactions | 9.60e-05 | 58 | 31 | 3 | int:INSL5 | |
| Interaction | CREB5 interactions | 1.12e-04 | 164 | 31 | 4 | int:CREB5 | |
| Interaction | LIPG interactions | 1.29e-04 | 64 | 31 | 3 | int:LIPG | |
| Interaction | OIT3 interactions | 1.35e-04 | 65 | 31 | 3 | int:OIT3 | |
| Interaction | BAHD1 interactions | 1.48e-04 | 67 | 31 | 3 | int:BAHD1 | |
| Interaction | PTPRK interactions | 1.50e-04 | 177 | 31 | 4 | int:PTPRK | |
| Interaction | VGLL3 interactions | 1.83e-04 | 72 | 31 | 3 | int:VGLL3 | |
| Interaction | ATN1 interactions | 1.86e-04 | 187 | 31 | 4 | int:ATN1 | |
| Interaction | TMEM87A interactions | 1.86e-04 | 187 | 31 | 4 | int:TMEM87A | |
| Interaction | MAPKBP1 interactions | 1.98e-04 | 74 | 31 | 3 | int:MAPKBP1 | |
| Interaction | LCE3A interactions | 2.15e-04 | 76 | 31 | 3 | int:LCE3A | |
| Interaction | PRSS37 interactions | 2.37e-04 | 15 | 31 | 2 | int:PRSS37 | |
| Interaction | SAXO4 interactions | 2.50e-04 | 80 | 31 | 3 | int:SAXO4 | |
| Interaction | GATA5 interactions | 3.07e-04 | 17 | 31 | 2 | int:GATA5 | |
| Interaction | REN interactions | 3.07e-04 | 17 | 31 | 2 | int:REN | |
| Interaction | LY86 interactions | 3.27e-04 | 217 | 31 | 4 | int:LY86 | |
| Interaction | SCGB2A2 interactions | 3.63e-04 | 223 | 31 | 4 | int:SCGB2A2 | |
| Interaction | LCE1F interactions | 3.77e-04 | 92 | 31 | 3 | int:LCE1F | |
| Interaction | TSHR interactions | 4.27e-04 | 96 | 31 | 3 | int:TSHR | |
| Interaction | COMP interactions | 4.28e-04 | 20 | 31 | 2 | int:COMP | |
| Interaction | INCA1 interactions | 4.72e-04 | 239 | 31 | 4 | int:INCA1 | |
| Interaction | DEFA1 interactions | 4.82e-04 | 100 | 31 | 3 | int:DEFA1 | |
| Interaction | BEX2 interactions | 5.71e-04 | 106 | 31 | 3 | int:BEX2 | |
| Interaction | KRTAP11-1 interactions | 6.03e-04 | 108 | 31 | 3 | int:KRTAP11-1 | |
| Interaction | PCSK5 interactions | 6.71e-04 | 112 | 31 | 3 | int:PCSK5 | |
| Interaction | BRINP3 interactions | 6.72e-04 | 25 | 31 | 2 | int:BRINP3 | |
| Interaction | TRADD interactions | 6.88e-04 | 113 | 31 | 3 | int:TRADD | |
| Interaction | PROC interactions | 7.27e-04 | 26 | 31 | 2 | int:PROC | |
| Interaction | P2RX7 interactions | 7.27e-04 | 26 | 31 | 2 | int:P2RX7 | |
| Interaction | CRYBA2 interactions | 8.44e-04 | 28 | 31 | 2 | int:CRYBA2 | |
| Interaction | LAMB2 interactions | 8.60e-04 | 122 | 31 | 3 | int:LAMB2 | |
| Interaction | ALPP interactions | 8.80e-04 | 123 | 31 | 3 | int:ALPP | |
| Interaction | EFEMP1 interactions | 8.80e-04 | 123 | 31 | 3 | int:EFEMP1 | |
| Interaction | SPSB4 interactions | 9.01e-04 | 124 | 31 | 3 | int:SPSB4 | |
| Interaction | ITGB4 interactions | 9.22e-04 | 125 | 31 | 3 | int:ITGB4 | |
| Interaction | CATSPER1 interactions | 9.44e-04 | 126 | 31 | 3 | int:CATSPER1 | |
| Interaction | COL4A3 interactions | 9.70e-04 | 30 | 31 | 2 | int:COL4A3 | |
| Interaction | IL17F interactions | 1.04e-03 | 31 | 31 | 2 | int:IL17F | |
| Interaction | LILRA5 interactions | 1.10e-03 | 32 | 31 | 2 | int:LILRA5 | |
| Interaction | MSTN interactions | 1.17e-03 | 33 | 31 | 2 | int:MSTN | |
| Interaction | MEGF10 interactions | 1.17e-03 | 33 | 31 | 2 | int:MEGF10 | |
| Interaction | NXPH2 interactions | 1.17e-03 | 33 | 31 | 2 | int:NXPH2 | |
| Interaction | GFI1B interactions | 1.18e-03 | 136 | 31 | 3 | int:GFI1B | |
| Interaction | AQP1 interactions | 1.23e-03 | 138 | 31 | 3 | int:AQP1 | |
| Interaction | VEGFB interactions | 1.25e-03 | 34 | 31 | 2 | int:VEGFB | |
| Interaction | FARS2 interactions | 1.31e-03 | 141 | 31 | 3 | int:FARS2 | |
| Interaction | WNT11 interactions | 1.32e-03 | 35 | 31 | 2 | int:WNT11 | |
| Interaction | DBF4B interactions | 1.40e-03 | 36 | 31 | 2 | int:DBF4B | |
| Interaction | TRIM42 interactions | 1.53e-03 | 149 | 31 | 3 | int:TRIM42 | |
| Interaction | KLK15 interactions | 1.59e-03 | 151 | 31 | 3 | int:KLK15 | |
| Interaction | OTX1 interactions | 1.71e-03 | 155 | 31 | 3 | int:OTX1 | |
| Interaction | STK16 interactions | 1.71e-03 | 155 | 31 | 3 | int:STK16 | |
| Interaction | CRISP2 interactions | 1.72e-03 | 40 | 31 | 2 | int:CRISP2 | |
| Interaction | TBX6 interactions | 1.81e-03 | 41 | 31 | 2 | int:TBX6 | |
| Interaction | PSG8 interactions | 1.81e-03 | 41 | 31 | 2 | int:PSG8 | |
| Interaction | TCEA2 interactions | 1.84e-03 | 159 | 31 | 3 | int:TCEA2 | |
| Interaction | DEFB135 interactions | 1.90e-03 | 42 | 31 | 2 | int:DEFB135 | |
| Interaction | NELL1 interactions | 1.90e-03 | 42 | 31 | 2 | int:NELL1 | |
| Interaction | KRTAP4-12 interactions | 1.91e-03 | 161 | 31 | 3 | int:KRTAP4-12 | |
| Interaction | FGF4 interactions | 2.08e-03 | 44 | 31 | 2 | int:FGF4 | |
| Interaction | AGXT interactions | 2.08e-03 | 44 | 31 | 2 | int:AGXT | |
| Interaction | ZBTB25 interactions | 2.08e-03 | 44 | 31 | 2 | int:ZBTB25 | |
| Interaction | SSC4D interactions | 2.18e-03 | 45 | 31 | 2 | int:SSC4D | |
| Interaction | CMA1 interactions | 2.27e-03 | 46 | 31 | 2 | int:CMA1 | |
| Interaction | KRTAP19-2 interactions | 2.37e-03 | 47 | 31 | 2 | int:KRTAP19-2 | |
| Interaction | TAFA2 interactions | 2.37e-03 | 47 | 31 | 2 | int:TAFA2 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr9q34 | 1.36e-03 | 325 | 31 | 3 | chr9q34 | |
| Cytoband | 9q34.3 | 2.35e-03 | 106 | 31 | 2 | 9q34.3 | |
| GeneFamily | Laminin subunits | 3.42e-07 | 12 | 22 | 3 | 626 | |
| GeneFamily | C2-set domain containing|Immunoglobulin like domain containing|Scavenger receptors | 4.49e-06 | 27 | 22 | 3 | 1253 | |
| GeneFamily | Blood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing | 1.62e-02 | 161 | 22 | 2 | 593 | |
| Coexpression | NABA_BASEMENT_MEMBRANES | 6.11e-12 | 40 | 31 | 6 | M5887 | |
| Coexpression | NABA_CORE_MATRISOME | 1.89e-11 | 270 | 31 | 9 | MM17057 | |
| Coexpression | NABA_CORE_MATRISOME | 2.23e-11 | 275 | 31 | 9 | M5884 | |
| Coexpression | NABA_MATRISOME | PCSK5 KCP LAMA3 LAMA5 LAMB2 HSPG2 VWF SCUBE2 HMCN1 MEGF11 MEGF10 MATN2 NTN3 | 4.04e-11 | 1008 | 31 | 13 | MM17056 |
| Coexpression | NABA_ECM_GLYCOPROTEINS | 4.69e-11 | 191 | 31 | 8 | MM17059 | |
| Coexpression | NABA_MATRISOME | PCSK5 KCP LAMA3 LAMA5 LAMB2 HSPG2 VWF SCUBE2 HMCN1 MEGF11 MEGF10 MATN2 NTN3 | 5.03e-11 | 1026 | 31 | 13 | M5889 |
| Coexpression | NABA_ECM_GLYCOPROTEINS | 5.77e-11 | 196 | 31 | 8 | M3008 | |
| Coexpression | NABA_MATRISOME_BLEO_FIBROTIC_LUNG | 7.65e-09 | 20 | 31 | 4 | MM17053 | |
| Coexpression | HEBERT_MATRISOME_TNBC_LUNG_METASTASIS | 1.40e-08 | 23 | 31 | 4 | M48001 | |
| Coexpression | PEREZ_TP53_TARGETS | 5.83e-05 | 1201 | 31 | 8 | M4391 | |
| Coexpression | NABA_MATRISOME_HIGHLY_METASTATIC_MELANOMA_TUMOR_CELL_DERIVED | 8.87e-05 | 12 | 31 | 2 | M47983 | |
| Coexpression | BOQUEST_STEM_CELL_DN | 1.23e-04 | 218 | 31 | 4 | M1578 | |
| Coexpression | FAN_EMBRYONIC_CTX_BRAIN_ENDOTHELIAL_1 | 1.54e-04 | 440 | 31 | 5 | M39039 | |
| Coexpression | FEKIR_HEPARG_SIDE_POP_VS_HEPARG_UP | 1.64e-04 | 90 | 31 | 3 | M48360 | |
| Coexpression | NABA_MATRISOME_HIGHLY_METASTATIC_MELANOMA | 2.05e-04 | 18 | 31 | 2 | M47984 | |
| Coexpression | GAO_LARGE_INTESTINE_24W_C1_DCLK1POS_PROGENITOR | 2.18e-04 | 99 | 31 | 3 | M39152 | |
| Coexpression | WATANABE_ULCERATIVE_COLITIS_WITH_CANCER_UP | 2.29e-04 | 19 | 31 | 2 | M12084 | |
| Coexpression | LIM_MAMMARY_STEM_CELL_UP | 2.29e-04 | 479 | 31 | 5 | M2573 | |
| Coexpression | LIM_MAMMARY_STEM_CELL_UP | 2.38e-04 | 483 | 31 | 5 | MM1082 | |
| Coexpression | GAO_LARGE_INTESTINE_ADULT_CJ_IMMUNE_CELLS | 2.92e-04 | 505 | 31 | 5 | M39167 | |
| Coexpression | DITTMER_PTHLH_TARGETS_UP | 3.21e-04 | 113 | 31 | 3 | M11090 | |
| Coexpression | GAO_LARGE_INTESTINE_24W_C2_MKI67POS_PROGENITOR | 3.21e-04 | 113 | 31 | 3 | M39153 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C3_GRIA2_POS_ARTERIAL_ENDO_CELL | 3.38e-04 | 115 | 31 | 3 | M45752 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C3_ARTERIAL_ENDOTHELIAL_CELL | 3.46e-04 | 286 | 31 | 4 | M45746 | |
| Coexpression | VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN | 5.40e-04 | 135 | 31 | 3 | M5825 | |
| Coexpression | GSE11367_CTRL_VS_IL17_TREATED_SMOOTH_MUSCLE_CELL_UP | 5.64e-04 | 137 | 31 | 3 | M460 | |
| CoexpressionAtlas | Stromal Cells, BEC.MLN, gp38- CD31+, Lymph Node, avg-5 | 3.39e-06 | 456 | 31 | 7 | GSM777032_500 | |
| CoexpressionAtlas | Stromal Cells, BEC.SLN, gp38- CD31+, Lymph Node, avg-4 | 3.54e-06 | 459 | 31 | 7 | GSM777037_500 | |
| CoexpressionAtlas | Stromal Cells, FRC.MLN, gp38+ CD31- CD140a+, Lymph Node, avg-5 | 3.91e-06 | 466 | 31 | 7 | GSM777050_500 | |
| CoexpressionAtlas | facebase_RNAseq_e14.5_palate_poster_nasal_Tgfbr2_WT_2500_K2 | 5.85e-06 | 1228 | 31 | 10 | facebase_RNAseq_e14.5_palate_poster_nasal_Tgfbr2_WT_2500_K2 | |
| CoexpressionAtlas | mendel_RNAseq_e12.5_Urothelium_ShhCreRFP_2500_K1 | 2.69e-04 | 402 | 31 | 5 | mendel_RNAseq_e12.5_Urothelium_ShhCreRFP_2500_K1 | |
| CoexpressionAtlas | JC_hmvEC_top-relative-expression-ranked_500_k-means-cluster#1 | 2.78e-04 | 219 | 31 | 4 | JC_hmvEC_500_K1 | |
| CoexpressionAtlas | dev gonad_e12.5_F_SupCellPrec_Sry_k-means-cluster#3_top-relative-expression-ranked_1000 | 2.94e-04 | 89 | 31 | 3 | gudmap_dev gonad_e12.5_F_SupCellPrec_Sry_k3_1000 | |
| CoexpressionAtlas | Stromal Cells, Fi.Sk, gp38+ CD140a+, Skin, avg-4 | 3.94e-04 | 437 | 31 | 5 | GSM777046_500 | |
| CoexpressionAtlas | Stromal Cells, LEC.MLN, gp38+ CD31+, Lymph Node, avg-4 | 4.03e-04 | 439 | 31 | 5 | GSM777059_500 | |
| CoexpressionAtlas | Stromal Cells, Fi.MTS15+.Th, CD45- PDGFRa+ MTS15+, Thymus, avg-3 | 4.28e-04 | 445 | 31 | 5 | GSM777043_500 | |
| CoexpressionAtlas | Stromal Cells, St.31-38-44-.SLN, CD45- gp38- CD31- CD44-, Lymph Node, avg-2 | 4.65e-04 | 453 | 31 | 5 | GSM777067_500 | |
| CoexpressionAtlas | Stromal Cells, FRC.SLN, gp38+ CD31- CD140a+, Lymph Node, avg-4 | 4.74e-04 | 455 | 31 | 5 | GSM777055_500 | |
| ToppCell | AT1-AT2_cells-Cryobiopsy_01|World / lung cells shred on cell class, cell subclass, sample id | 1.95e-09 | 172 | 31 | 6 | 0be41df5d35d818deb7316ac21c9366eb4b7bfd1 | |
| ToppCell | Basal|World / shred by cell class for mouse tongue | 2.82e-09 | 183 | 31 | 6 | c6729a207526ff4aa48176207b9353176f631fea | |
| ToppCell | 10x5'v1-week_17-19-Endothelial-stroma-sinusoidal_EC|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 4.13e-09 | 195 | 31 | 6 | 22a481927147ec4ae9d59e6af7c87df0e9cb51e4 | |
| ToppCell | 10x3'2.3-week_17-19-Endothelial-stroma-sinusoidal_EC|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 4.39e-09 | 197 | 31 | 6 | 4e58bbf3ecb30b4c8199adcc04d2eb134d90de56 | |
| ToppCell | Fibroblasts-DKK3+_Fibroblasts|World / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 4.52e-09 | 198 | 31 | 6 | 4f4632f26a2043c5e4ab89031b4229b5dca1bd48 | |
| ToppCell | 3'-Parenchyma_lung-Endothelial-Blood_vessel_EC-pulmonary_artery_endothelial_cell-EC_arterial-EC_arterial_L.2.4.1.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.47e-07 | 179 | 31 | 5 | d2db9e70b780643f1e004c41a70464d0abe26088 | |
| ToppCell | 10x3'2.3-week_17-19-Endothelial-stroma-proliferating_EC|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 1.78e-07 | 186 | 31 | 5 | a844d4f79e0ad5d6c60a4488ffd8f4f21b7eed04 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Descending_Vasa_Recta_Endothelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.93e-07 | 189 | 31 | 5 | 6463890d8dbee4bc198f91628a5f784970de786a | |
| ToppCell | LPS_only-Endothelial-Endothelial-Artery|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.93e-07 | 189 | 31 | 5 | b028466fcd36fdeceec752e55a24286a1cd62ae4 | |
| ToppCell | facs-Limb_Muscle-ForelimbandHindlimb-3m-Endothelial|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.98e-07 | 190 | 31 | 5 | bb1476b44dd49e1dd52a636a91c4600b6d4fbe2e | |
| ToppCell | facs-Limb_Muscle-ForelimbandHindlimb-3m-Endothelial-nan|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.98e-07 | 190 | 31 | 5 | d180205c70b5ca9bc5a01a2e6cb42fcebc7f630d | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial-Artery|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.98e-07 | 190 | 31 | 5 | aed65d584ca0c25f6a8313c66b421a6618af82ea | |
| ToppCell | facs-Limb_Muscle-ForelimbandHindlimb-3m-Endothelial-endothelial_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.98e-07 | 190 | 31 | 5 | 38a815abf0ac5cac6071737cadc54a514f62d37d | |
| ToppCell | LPS-antiTNF-Endothelial-Endothelial-Artery|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.03e-07 | 191 | 31 | 5 | 4b3d5157344dbfbf4fab518611cd9fa37fac7bd9 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Descending_Vasa_Recta_Endothelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.09e-07 | 192 | 31 | 5 | 56b021c297a21dff357531f21e2464f85186106d | |
| ToppCell | 15-Trachea-Endothelial-Endothelial|Trachea / Age, Tissue, Lineage and Cell class | 2.14e-07 | 193 | 31 | 5 | 6ea0444fc3dc156997129387184e6418947f4b12 | |
| ToppCell | 15-Trachea-Endothelial|Trachea / Age, Tissue, Lineage and Cell class | 2.14e-07 | 193 | 31 | 5 | b1ebf8df2d55e2938e5a495ea68b80c4ac216dc0 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Descending_Vasa_Recta_Endothelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.25e-07 | 195 | 31 | 5 | 6bdef651cf73d7381e5012d0eb3c809138fb6b92 | |
| ToppCell | ASK428-Endothelial-Endothelium|ASK428 / Donor, Lineage and Cell class of Lung cells from Dropseq | 2.31e-07 | 196 | 31 | 5 | b1a81eddb91fb462360692b7b0a3ba4a947eac40 | |
| ToppCell | Tracheal-NucSeq-Epithelial-Epi_submucosal-gland-Myoepithelial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.37e-07 | 197 | 31 | 5 | f0475ad9c09c6da418dba17d3d3c1aaa2ef9ab4e | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-1m-Mesenchymal|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.43e-07 | 198 | 31 | 5 | b086af292a508a156266c2d899ba1caf820bf61c | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Endothelial-Endothelial_immature-Tip-like-A|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.43e-07 | 198 | 31 | 5 | 72e8b9cccb7b0a2ea9d415218fff4fa2f09728f4 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-1m-Mesenchymal-mesenchymal_stem_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.43e-07 | 198 | 31 | 5 | 1b90d632e59c3c47b936e829cceeb0334f05f34f | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-1m-Mesenchymal-chondrocyte-like|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.43e-07 | 198 | 31 | 5 | 524305c5d7b1d53e86ec0af775efefa3e0955e47 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Endothelial|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.43e-07 | 198 | 31 | 5 | e1fa02184ce93c4f8aa5cf04b70949cd4c425ff0 | |
| ToppCell | Tracheal-NucSeq-Epithelial-Epi_airway_basal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.43e-07 | 198 | 31 | 5 | 5374b0e98d669f36a0571d3c006c7bd5e3c8e87f | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Endothelial-Endothelial_immature|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.49e-07 | 199 | 31 | 5 | 9c40b3ee39860e9d8edafd007daec11abdd95435 | |
| ToppCell | Tracheal-NucSeq-Epithelial-Epi_airway_basal-Basal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.49e-07 | 199 | 31 | 5 | 94a7867e800df352731796de8c24cba133c29622 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_myocytic-Myofibroblastic|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 2.49e-07 | 199 | 31 | 5 | e9820d5fb4e8b46973c4c50ac5db8fb4a1bf603b | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell-Scavenging_endothelial|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.49e-07 | 199 | 31 | 5 | d95d78b2ebc9a20532466e4d4be579b4faf6776f | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Endothelial-Endothelial_mature-Endo_arterial|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.49e-07 | 199 | 31 | 5 | 0602e2b2aa56d106da63bd342a38bef437b4d496 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell-Scavenging_endothelial-F|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.49e-07 | 199 | 31 | 5 | cdcfca94baba66e213cc3ffb0cfb4c75d6ab44ec | |
| ToppCell | droplet-Limb_Muscle-nan-3m-Mesenchymal-chondrocyte-like|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.49e-07 | 199 | 31 | 5 | edd5300da1a3b758210ff8f949e9d1988b8bc7e2 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Endothelial-Endothelial_mature-Endo_arterial-F|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.49e-07 | 199 | 31 | 5 | 463ba77dc4c85eebb343f29a42c7ac889b0497c9 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Endothelial-Endothelial_immature-Tip-like|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.49e-07 | 199 | 31 | 5 | 72b34bce8157abe389e95cd3ed8ba578dce0cbf6 | |
| ToppCell | Tracheal-10x5prime-Epithelial-Epi_airway_basal-Basal|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 2.55e-07 | 200 | 31 | 5 | 9da214f756a03516eaafde00289b90f69623b9f3 | |
| ToppCell | 10x5'v1-week_14-16-Endothelial-stroma-sinusoidal_EC|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 2.55e-07 | 200 | 31 | 5 | ae429f2de652cc1976e63644781197e9ce0e70c8 | |
| ToppCell | 10x5'v1-week_14-16-Endothelial-stroma|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 2.55e-07 | 200 | 31 | 5 | 2488aa12970a43a5af352e2c36c73884d73a1cc5 | |
| ToppCell | Bronchus_Control_(B.)-Epithelial-TX-Basal_3|Bronchus_Control_(B.) / Sample group, Lineage and Cell type | 2.55e-07 | 200 | 31 | 5 | 06b59ee536414d1f73c1e17cdfd7c3f2259b9bef | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Endothelial-Endothelial_mature|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.55e-07 | 200 | 31 | 5 | 86ec951234015ced7126b016199e5869a0f22478 | |
| ToppCell | Lung_Parenchyma-Severe-Epithelial-Epithelial-Basal_1-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.55e-07 | 200 | 31 | 5 | 8cfbde43c5e66269ad128aa5398b1517667d7d36 | |
| ToppCell | Bronchial-10x5prime-Endothelial-Endothelia_vascular-VE_pulmonary_arterial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 2.55e-07 | 200 | 31 | 5 | 7547d6339f9380d031cfd2cce21ac9a12491e085 | |
| ToppCell | 10x5'v1-week_14-16-Endothelial|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 2.55e-07 | 200 | 31 | 5 | e786544cf6f891550c4be55ebb4928c92297b504 | |
| ToppCell | LPS_only-Endothelial-Endothelial-Artery|LPS_only / Treatment groups by lineage, cell group, cell type | 2.55e-07 | 200 | 31 | 5 | b17eb1587ca86c3d40515128a00a8d8fd787fccf | |
| ToppCell | Parenchyma_COVID-19-Epithelial-TX-Basal_1|Parenchyma_COVID-19 / Sample group, Lineage and Cell type | 2.55e-07 | 200 | 31 | 5 | 592c7c3ded409a9957cbcdc62fcc213fa8eae598 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Endothelial|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.55e-07 | 200 | 31 | 5 | 061ba851f941c616ddb462512e826c412881c3ce | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Artery|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 2.55e-07 | 200 | 31 | 5 | ac9ead34afa14067171833f5c277eaf06db7b02e | |
| ToppCell | Lung_Parenchyma-Severe-Epithelial-Epithelial-Basal_1|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 2.55e-07 | 200 | 31 | 5 | 61811380d9252f12f27b7ad4752380b52692677f | |
| ToppCell | wk_15-18-Mesenchymal-Myofibro_&_SMC-Myofibro_2|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 4.17e-06 | 157 | 31 | 4 | b9d04ee417c0d8ea0801d10f1c54e138587009fd | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-24m-Endothelial-endothelial_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.28e-06 | 158 | 31 | 4 | a2efcc184ef13d81373e3690253ba35f6be09c5f | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-24m-Endothelial-Endothelial_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.28e-06 | 158 | 31 | 4 | ba9998cbf786c515d30fe42de02c7a246db1b6f9 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-24m-Endothelial|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.28e-06 | 158 | 31 | 4 | e52eff2bd1e7e0ce9c278ed5109802865e0fe69c | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.72e-06 | 162 | 31 | 4 | c399b9e4854916a59f5cae2d8dbf19660f8759be | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell_|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.72e-06 | 162 | 31 | 4 | a291248b693c771845174393934a782f1d8bd7ce | |
| ToppCell | facs-Heart-RA-18m-Endothelial-endothelial_cell_of_endocardium|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.46e-06 | 168 | 31 | 4 | 06dc5b2d356d3a9454b10bba6f3b9ead2a0a7d46 | |
| ToppCell | Adult-Endothelial-endothelial_cell_of_artery-D122|Adult / Lineage, Cell type, age group and donor | 5.46e-06 | 168 | 31 | 4 | 8c3e1e45b422813bcdfa4273b1167db649a312f5 | |
| ToppCell | facs-Heart-RA-18m-Endothelial-endocardial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.46e-06 | 168 | 31 | 4 | 1002f058a340763e3d8de0bd1f0547a903526ec6 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Non-neuronal-Mesenchymal-Mes-Myofibroblast|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.72e-06 | 170 | 31 | 4 | 489fc97f6002a577b882a8ff3c563b1e42041d38 | |
| ToppCell | 3'-Broncho-tracheal-Endothelial-Blood_vessel_EC-vein_endothelial_cell-EC_venous_pulmonary-EC_venous_pulmonary_L.2.2.1.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.72e-06 | 170 | 31 | 4 | 1a568efcff9c39b3f709b55a05d24710450a2657 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Non-neuronal-Mesenchymal-Mes-Myofibroblast-VLMC_L1-3_CYP1B1|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.72e-06 | 170 | 31 | 4 | 7d736e741799b67a7f022fc6766841c951ef8951 | |
| ToppCell | 3'-Broncho-tracheal-Endothelial-Blood_vessel_EC-vein_endothelial_cell-EC_venous_pulmonary|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.72e-06 | 170 | 31 | 4 | 66d41d794790e621d72ac37af995510537103c9c | |
| ToppCell | Endothelial-A-IPF_03|World / lung cells shred on cell class, cell subclass, sample id | 5.99e-06 | 172 | 31 | 4 | a3201773a25832e92dd113fad165f1ecd37f5e91 | |
| ToppCell | wk_15-18-Endothelial-Blood_vessel_endothelial-arterial_endo|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 6.13e-06 | 173 | 31 | 4 | 3a9e9a09b3eeb37cbe56d650e112a8398879477f | |
| ToppCell | facs-Heart-RA-24m-Endothelial-endothelial_cell_of_endocardium|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.27e-06 | 174 | 31 | 4 | 42dfb6f42b72e40e203b3ef341117bccf3553d54 | |
| ToppCell | metastatic_Lymph_Node-Endothelial_cells-Lymphatic_ECs|metastatic_Lymph_Node / Location, Cell class and cell subclass | 6.27e-06 | 174 | 31 | 4 | d551bc29afef071adf4c9bb80345352ec33441d8 | |
| ToppCell | facs-Heart-RA-24m-Endothelial-endocardial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.27e-06 | 174 | 31 | 4 | f04edf2ca6788875c9918611e416fb739924382e | |
| ToppCell | wk_15-18-Epithelial-Distal_epithelial-type_I_pneumocyte|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 6.27e-06 | 174 | 31 | 4 | 2cd6638b361ca05ab83d09ce657194aed97873b7 | |
| ToppCell | facs-Trachea-18m-Mesenchymal-fibroblast-fibroblast_of_trachea-tracheal_fibroblast_l20-1|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.27e-06 | 174 | 31 | 4 | 1d157f7a919c8246e83d8060d2a0017c6c781ef3 | |
| ToppCell | wk_20-22-Endothelial-Blood_vessel_endothelial-OMD+_endo|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 6.56e-06 | 176 | 31 | 4 | 52af8f717dbd3b59eeb868b8b7b256a8f3e57d7a | |
| ToppCell | AT1_cells-HP_01|World / lung cells shred on cell class, cell subclass, sample id | 6.56e-06 | 176 | 31 | 4 | 458720776b0151cd55acc352d509599cb62f0ca8 | |
| ToppCell | facs-Lung-24m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l25-31|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.70e-06 | 177 | 31 | 4 | 6b4fe717928814dafcd13090b1c90ea973938c6d | |
| ToppCell | facs-Marrow-Granulocytes-24m-Hematologic-MPP_Fraction_B|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.70e-06 | 177 | 31 | 4 | 4a697866ed542d3201714234cee03451adf1dcc9 | |
| ToppCell | TCGA-Ovary-Primary_Tumor-Ovarian_Carcinoma-Serous_Cystadenocarcinoma-6|TCGA-Ovary / Sample_Type by Project: Shred V9 | 6.86e-06 | 178 | 31 | 4 | 142879e9393e721f9b05a6bb46995c9d6d713c95 | |
| ToppCell | 3'-Adult-Distal_Rectal-Endothelial-blood_vessel_EC-Mature_arterial_EC|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.86e-06 | 178 | 31 | 4 | c30d3390fc4a7856f50ba8ff6694c0333165ddde | |
| ToppCell | wk_08-11-Epithelial-PNS-Proliferating_Schwann|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 7.01e-06 | 179 | 31 | 4 | ab23fee9adab1e63d5b5cd9faba6b9a92beef425 | |
| ToppCell | AT1_cells-Cryobiopsy_01|World / lung cells shred on cell class, cell subclass, sample id | 7.01e-06 | 179 | 31 | 4 | 1603117b52623663458a977c94bf7f9f6c1114b8 | |
| ToppCell | wk_08-11-Endothelial-Blood_vessel_endothelial-Venous_endo|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 7.01e-06 | 179 | 31 | 4 | 040a7e916baaf81f44339dc721ab2afcd2c22388 | |
| ToppCell | facs-Lung-18m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell-pulmonary_artery_endothelial_cell_l25|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 7.16e-06 | 180 | 31 | 4 | 67c5068b660cd5e727a665cefe3bd5f8ae887221 | |
| ToppCell | droplet-Limb_Muscle-Pre-Sort|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.16e-06 | 180 | 31 | 4 | af2bafcd1b2082629de3ea336711add01565c4c4 | |
| ToppCell | systemic_lupus_erythematosus-treated-Hematopoietic-progenitor_cell|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 7.16e-06 | 180 | 31 | 4 | 2694f5deaed551c53e74d8a9fbd41d3734bb9f37 | |
| ToppCell | PCW_05-06-Endothelial-Endothelial_mature-endo_arterial_(9)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 7.16e-06 | 180 | 31 | 4 | 5861b44acfb8fe92c281c8355bf19c059b3dcd64 | |
| ToppCell | systemic_lupus_erythematosus-treated-Hematopoietic-progenitor_cell-female|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 7.16e-06 | 180 | 31 | 4 | ef0de602fc8ccfd32a06978ac0100afe0ce1beeb | |
| ToppCell | AT1_cells-Donor_08|World / lung cells shred on cell class, cell subclass, sample id | 7.16e-06 | 180 | 31 | 4 | 2d52cb5f77dde0e3dccac1333d4ec67ec680fcb2 | |
| ToppCell | droplet-Limb_Muscle-Pre-Sort-18m|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.16e-06 | 180 | 31 | 4 | f29a995cf6e1a1836ed68b73258d9370bf3d4434 | |
| ToppCell | droplet-Lung-1m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell-pulmonary_artery_endothelial_cell_l25|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 7.32e-06 | 181 | 31 | 4 | 136b0c60680068838d184d32aa99d7bea8718dbc | |
| ToppCell | facs-Lung-18m-Endothelial-arterial_endothelial|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 7.48e-06 | 182 | 31 | 4 | ebc812ed3f25839ea25f76b952c463d79a8325b1 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Endothelial-blood_vessel_EC-Fetal_venous_EC|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.48e-06 | 182 | 31 | 4 | d0e3663f7d39f22a3ebd7fde56ab3504773598f4 | |
| ToppCell | Control-Epithelial-Basal|World / Disease state, Lineage and Cell class | 7.48e-06 | 182 | 31 | 4 | 759390dde9b18757f7675d13d44c89d0e32f8d93 | |
| ToppCell | droplet-Lung-21m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 7.48e-06 | 182 | 31 | 4 | c7f2d24697affa530b748ab32b1d40bdc1bdc20a | |
| ToppCell | facs-Lung-3m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l25-31|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 7.48e-06 | 182 | 31 | 4 | a1c0e4090a9e7aa4941a40c817d178de144888b6 | |
| ToppCell | droplet-Lung-21m-Endothelial-arterial_endothelial|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 7.48e-06 | 182 | 31 | 4 | d95635b74e8cd8bc00bfe40340806b59fb9bee43 | |
| ToppCell | facs-Lung-18m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 7.48e-06 | 182 | 31 | 4 | 47ff6b4002a4167412c79210651316d1342503f9 | |
| ToppCell | facs-Lung-nan-3m-Endothelial-Artery_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.65e-06 | 183 | 31 | 4 | 12e876d6205af8aad74265c668b5e95b9e7487f3 | |
| ToppCell | 5'-Adult-LymphNode-Endothelial-blood_vessel_EC-Mature_venous_EC|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.65e-06 | 183 | 31 | 4 | a644258ba90acc62d571623e429d72ffc4b69203 | |
| ToppCell | IPF-Epithelial-ATI|World / Disease state, Lineage and Cell class | 7.65e-06 | 183 | 31 | 4 | 31fef35ecf30162662f24d335d8f0cceacc07039 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell_|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.65e-06 | 183 | 31 | 4 | dc19857b66dcadbf7c87de91f7b1f4e8ef2857ed | |
| ToppCell | droplet-Heart-4Chambers-18m-Endothelial-endocardial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.65e-06 | 183 | 31 | 4 | 6c4a09c02e30e1f24dde39f8cb8c5b453826ee2e | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.65e-06 | 183 | 31 | 4 | 4759560e5b4f4e5a00e5f933e3451a27c7c4aefe | |
| ToppCell | droplet-Heart-HEART_(LV+RV_ONLY)-30m-Endothelial-endocardial_endothelial_cells|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.65e-06 | 183 | 31 | 4 | b0b5a41f1a40f9c946d0dc8b67eaccdd9f9b73a5 | |
| ToppCell | 343B-Fibroblasts-Fibroblast-E|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 7.98e-06 | 185 | 31 | 4 | 02cbf492bc40abebaa93a3a208888afae72fbe06 | |
| Computational | Adhesion molecules. | 7.47e-08 | 141 | 18 | 6 | MODULE_122 | |
| Computational | Immune / stress response genes. | 2.54e-05 | 383 | 18 | 6 | MODULE_33 | |
| Computational | DRG (dorsal root ganglia) genes. | 2.58e-05 | 384 | 18 | 6 | MODULE_2 | |
| Computational | Ovary genes. | 2.71e-04 | 368 | 18 | 5 | MODULE_1 | |
| Computational | Trachea genes. | 4.73e-04 | 415 | 18 | 5 | MODULE_6 | |
| Computational | Lung genes. | 5.81e-04 | 434 | 18 | 5 | MODULE_5 | |
| Computational | Placenta genes. | 7.80e-04 | 463 | 18 | 5 | MODULE_38 | |
| Computational | Metal / Ca ion binding. | 1.32e-03 | 133 | 18 | 3 | MODULE_324 | |
| Computational | Spinal cord (neuro-development) genes. | 2.61e-03 | 360 | 18 | 4 | MODULE_12 | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 3.09e-03 | 50 | 18 | 2 | GAVISH_3CA_METAPROGRAM_ENDOTHELIAL_NOTCH_SIGNALING | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 3.09e-03 | 50 | 18 | 2 | GAVISH_3CA_METAPROGRAM_ENDOTHELIAL_ENDO_3 | |
| Computational | Heart genes. | 4.66e-03 | 423 | 18 | 4 | MODULE_60 | |
| Computational | Cell line expressed genes. | 5.03e-03 | 432 | 18 | 4 | MODULE_52 | |
| Computational | Intermediate filaments and MT. | 5.65e-03 | 68 | 18 | 2 | MODULE_438 | |
| Drug | BM165 | 3.74e-07 | 11 | 31 | 3 | CID003352881 | |
| Drug | AC1L1G72 | 3.74e-07 | 11 | 31 | 3 | CID000003553 | |
| Drug | kalinin | 9.13e-07 | 55 | 31 | 4 | CID000032518 | |
| Drug | AC1L9INI | 1.21e-06 | 59 | 31 | 4 | CID000445839 | |
| Drug | ALT-711 | 2.99e-06 | 21 | 31 | 3 | CID000216304 | |
| Drug | Sikvav | 4.54e-06 | 24 | 31 | 3 | CID005487517 | |
| Drug | Grgds | 4.79e-06 | 83 | 31 | 4 | CID000123811 | |
| Drug | AC1L1B58 | 8.15e-06 | 29 | 31 | 3 | CID000001288 | |
| Drug | pyrachlostrobin | 9.53e-06 | 811 | 31 | 8 | ctd:C513428 | |
| Drug | 1-anilino-4-methyl-2-methylthio-4-phenylimidazolin-5-one | 9.67e-06 | 373 | 31 | 6 | ctd:C540355 | |
| Drug | Rgds Peptide | 1.27e-05 | 106 | 31 | 4 | CID000107775 | |
| Drug | Gdrgdsp | 1.42e-05 | 109 | 31 | 4 | CID000115346 | |
| Drug | B-Ms | 1.69e-05 | 114 | 31 | 4 | CID000445091 | |
| Drug | Calcort | 1.87e-05 | 38 | 31 | 3 | CID000026709 | |
| Drug | Ikvav | 1.87e-05 | 38 | 31 | 3 | CID000131343 | |
| Drug | quinaprilat | 2.72e-05 | 43 | 31 | 3 | CID000107994 | |
| Drug | 2,4-diaminopyrimidine | 5.41e-05 | 54 | 31 | 3 | CID000067431 | |
| Drug | Verteporfin [129497-78-5]; Down 200; 2.8uM; MCF7; HT_HG-U133A | 5.63e-05 | 155 | 31 | 4 | 6817_DN | |
| Drug | CC270 | 7.06e-05 | 59 | 31 | 3 | CID006918852 | |
| Drug | LG 5 | 7.42e-05 | 60 | 31 | 3 | CID011840957 | |
| Drug | DB04780 | 8.06e-05 | 170 | 31 | 4 | CID005459389 | |
| Drug | strontium phosphate | 1.17e-04 | 12 | 31 | 2 | CID000159737 | |
| Drug | Gramine [87-52-5]; Up 200; 23uM; MCF7; HT_HG-U133A | 1.29e-04 | 192 | 31 | 4 | 2799_UP | |
| Drug | dysprosium | 1.39e-04 | 74 | 31 | 3 | CID000023912 | |
| Drug | Sulfadiazine [68-35-9]; Down 200; 16uM; MCF7; HT_HG-U133A | 1.40e-04 | 196 | 31 | 4 | 5523_DN | |
| Drug | Enoxacin [74011-58-8]; Up 200; 12.4uM; MCF7; HT_HG-U133A | 1.40e-04 | 196 | 31 | 4 | 5251_UP | |
| Drug | A0395 | 1.44e-04 | 75 | 31 | 3 | CID009906466 | |
| Drug | Ganciclovir [82410-32-0]; Up 200; 15.6uM; HL60; HT_HG-U133A | 1.51e-04 | 200 | 31 | 4 | 3030_UP | |
| Drug | Amidopyrine [58-15-1]; Up 200; 17.2uM; PC3; HT_HG-U133A | 1.51e-04 | 200 | 31 | 4 | 4481_UP | |
| Drug | 2-amino-5-methylpyridine | 1.56e-04 | 77 | 31 | 3 | CID000015348 | |
| Drug | YIGSR | 1.68e-04 | 79 | 31 | 3 | CID000123977 | |
| Drug | HMQC | 1.86e-04 | 15 | 31 | 2 | CID006449980 | |
| Drug | 2-[(1R,2R,3S,4R,5R,6S)-2-[(2R,5S)-3-[(3S,4S,5R,6S)-4,5-dihydroxy-3-(methylamino)-6-methylol-tetrahydropyran-2-yl]-4-formyl-4-hydroxy-5-methylol-tetrahydrofuran-2-yl]oxy-5-guanidino-3,4,6-trihydroxy-cyclohexyl]guanidine | 1.95e-04 | 83 | 31 | 3 | CID011968896 | |
| Drug | NSC 714187 | 2.09e-04 | 85 | 31 | 3 | CID005288693 | |
| Drug | 1,2-dimethylhydrazine | 2.17e-04 | 86 | 31 | 3 | CID000001322 | |
| Drug | dermatan sulfate | 2.17e-04 | 220 | 31 | 4 | CID000032756 | |
| Drug | poly-N-acetyllactosamine | 2.32e-04 | 88 | 31 | 3 | CID000119547 | |
| Drug | H-9 dihydrochloride | 2.48e-04 | 90 | 31 | 3 | CID000003544 | |
| Drug | Rgd Peptide | 2.98e-04 | 239 | 31 | 4 | CID000104802 | |
| Drug | aniline mustard | 3.36e-04 | 20 | 31 | 2 | CID000011108 | |
| Drug | AC1O0B8G | 4.22e-04 | 262 | 31 | 4 | CID000091605 | |
| Drug | hyaluronan | 4.28e-04 | 263 | 31 | 4 | CID000024759 | |
| Drug | AC1L1C2F | 4.47e-04 | 110 | 31 | 3 | CID000001711 | |
| Disease | myopathy (implicated_via_orthology) | 1.59e-05 | 48 | 30 | 3 | DOID:423 (implicated_via_orthology) | |
| Disease | caffeine measurement | 1.04e-04 | 15 | 30 | 2 | EFO_0021177 | |
| Disease | Van Buchem disease | 1.35e-04 | 17 | 30 | 2 | C0432272 | |
| Disease | carotid artery disease (is_marker_for) | 1.69e-04 | 19 | 30 | 2 | DOID:3407 (is_marker_for) | |
| Disease | ferritin measurement | 2.40e-04 | 119 | 30 | 3 | EFO_0004459 | |
| Disease | lung small cell carcinoma (is_implicated_in) | 3.72e-04 | 28 | 30 | 2 | DOID:5409 (is_implicated_in) | |
| Disease | reticulocyte count | 5.57e-04 | 1045 | 30 | 6 | EFO_0007986 | |
| Disease | immature reticulocyte measurement | 7.61e-04 | 40 | 30 | 2 | EFO_0803545 | |
| Disease | platelet component distribution width | 9.07e-04 | 755 | 30 | 5 | EFO_0007984 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| PPAGRGDDIAHHCCC | 106 | A8MQ03 | |
| CHGHSEACEPETGAC | 1161 | P98160 | |
| ACSPGHSGRHCERCA | 1236 | P98160 | |
| CECLHGSGCREAQHD | 591 | Q14126 | |
| RCDCSHADGCHPTTG | 541 | Q96KG7 | |
| HHGCEDDPCPEGSEC | 3791 | Q14517 | |
| CDCSHADGCDPVTGH | 536 | A6BM72 | |
| LDSCALGDHGCEHSC | 526 | O00339 | |
| EHADGCEQGSGRCHC | 431 | Q16787 | |
| DCHCKSHVGGDSCDT | 651 | Q16787 | |
| GDHSCEGCDASCCSP | 666 | Q76N89 | |
| GLCEDLADGFHCHCP | 511 | Q9Y219 | |
| HTRCEEDNGGCSHLC | 296 | O75197 | |
| CHRACETCTGPGHDE | 1131 | Q92824 | |
| EGCASRCDCDHSDGC | 531 | Q5VY43 | |
| RCDCDHSDGCDPVHG | 536 | Q5VY43 | |
| GACLGCRDHTGGEHC | 891 | P55268 | |
| IGGRCVCHGHADACD | 296 | O15230 | |
| EACDPHSGHCLCKAG | 2031 | O15230 | |
| HGHDCCYTRAEEAGC | 86 | O15496 | |
| CALGRHTCHAGQDCD | 5151 | Q96RW7 | |
| HLICDCRHGTEGPDC | 271 | O00634 | |
| PCHECREDNDGEGHA | 376 | Q9BTV6 | |
| SHCDLAHGCCAPDGS | 31 | Q6UY11 | |
| HSCDDTADGPECSCH | 226 | Q9NQ36 | |
| TDADSPCHACHCQDG | 501 | Q6ZWJ8 | |
| HDCHHREDAGAVCDG | 391 | A1L4H1 | |
| CRAPCCGADVKAHHE | 166 | Q12933 | |
| HCEHGCPRHCDGNVS | 2211 | P04275 | |
| CPRHCDGNVSSCGDH | 2216 | P04275 | |
| CQDRFLGSGECHCHE | 1346 | Q9NY15 | |
| CTDGHRGGCSEHANC | 2136 | Q9NY15 | |
| ACHPRCAEHGTCKDG | 711 | Q9P273 | |
| RCGHRCSHPCGEDCV | 1381 | Q9P2E3 | |
| HEACKDPSRDCHHCG | 3301 | Q96JG9 | |
| CDGRPDCRDGSDEEH | 551 | Q8IU80 | |
| DCRDGSDEEHCDCGL | 556 | Q8IU80 | |
| GERPHECGECGKCFH | 456 | Q68DI1 |